The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China

<div>Kaplan-Meier survival curves of overall survival in smoking patients according to <i>EGFR</i> 19 deletion status.</div>

BioMed Research International

fig4

Figure 4

Figure 4: The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China 

Figure 4 | The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China 